Eternia - The Next Generation Des Engineered to Deliver Safety and Efficacy with proven Efficacy of Everolimus, Fully Bioresorable Polymer and Proprietary CoCr Stent Surface Finish, Safety and Efficacy is Demostrated By Eternia's Design
Entirely new innovation with unique features
Excellent flexibility and radial strength
Track ability as never before
Everolimus drug coated
Reduces artery injury
Next generation strut design offering excellent performance
Immensely thin struts to minimize the focal injury of vessel wall
Awesome surface finish
Drug Release Kinetics
ETERNIA has proven drug release kinetics. Initial burst release of everolimus followed by sustained release up to 40 days
Strut Thickness Matters
Eternia is the thinnest DES available in the market. Thin strut & polymer coating reduces injury to vessel wall and aid faster re-endothelialization thereby minimizing the risk of Thrombosis.